Clinical Trial Update: Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial exploring indocyanine green as a fluorescent agent to delineate surgical margins in cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Indocyanine Green (ICG) (indocyanine green)

Snippet

Sponsor: Emory University | Conditions: Malignant Neoplasm | Phase 1 | Status: COMPLETED